In 2023, the actual sold production of medicaments of other antibiotics not packaged for retail sale in Germany was valued at 248 million Euros. From 2024 to 2028, the forecasted growth shows an upward trend with values increasing from 259.67 million Euros to 307.26 million Euros. The year-on-year growth rate is approximately 4.64% for each successive year. Over the five-year forecast period, the compound annual growth rate (CAGR) is approximately 4.72%.
Future trends to watch for include potential regulatory changes, advances in medical technology that could impact production processes, and shifts in global demand influenced by antibiotic resistance and new healthcare policies. Additionally, economic factors and supply chain dynamics may also play critical roles in shaping production output.
